TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay March 28, 1980
TCL Archive NCI advisors approve $144 million program for nanotechnology centers, R01 grants, training. Three to five consortia envisioned. July 16, 2004
TCL Archive NIH Drops Objections To Bill For Research On Environmental Causes of Breast Cancer. May 23, 2008
